This white paper from PointCross Life Sciences Inc. (Foster City, CA) discusses the importance of unifying clinical trial data, molecular and other biomarkers from patient bio-samples for search and a unified vision to gain insights. We present the benefits of such a unified environment as a workbench for biomarker and translational researchers for discovering, developing, and applying biomarker for biologics based therapeutic drugs. The paper presents query masks for stratifying cohorts and search analytics on clinical and biomarker data as available on the Xbiom solution. It is not intended to be an original presentation of a scientific development. This paper will be periodically republished to reflect new information and user’s insights. We welcome comments from our industry clients – please send them to email@example.com.
Xbiom™ Workbench for Translational and Biomarker Research
Brief description of the Xbiom platform and solutions available
Xbiom™ is a commercially available stack of solutions for BioTechs and BioPharma. It is currently in production for both. It is available for immediate use through a public cloud instance in AWS (Amazon), or as a dedicated instance in the cloud or private cloud. It is also in production as an on-premise installation at some big Pharma companies.
Xbiom™ is built on top of the PointCross Ontology platform, Orchestra™. Xbiom™ uses a micro-services strategy to keep an evergreen architecture that is informed by biomarker and study data considerations, search, analytics, and immersive data visualization with a backdrop of security, workflow automation and artificial intelligence engines for machine learning.
Xbiom™ built on Orchestra™ Platform MySEND – Free Downloadable Desktop tool Regulatory: Nonclinical Regulatory: Clinical Smart Transformation Data Standardization SEND-ASSURE Services support regulatory processes in Clinical and Nonclinical; and it has workbenches for research in clinical translational and biomarkers and nonclinical. A brief description of modules supporting regulatory and nonclinical are listed below.